Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Evidence-based therapy for cutaneous sarcoidosis.

Robert P Baughman1, Elyse E Lower

  • 1Department of Internal Medicine, University of Cincinnati Medical Center, Cincinnati, OH 45220, USA. bob.baughman@uc.edu <bob.baughman@uc.edu>

Clinics in Dermatology
|June 15, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bridging the Gap: The Emerging Role of memory CD8+ T Cells in Fibrotic Interstitial Lung Disease.

American journal of respiratory cell and molecular biology·2026
Same author

Prevalence of relapse in pulmonary sarcoidosis: A systematic review and meta-analysis.

Respiratory medicine·2026
Same author

Safety and efficacy of namilumab for the treatment of chronic pulmonary sarcoidosis (RESOLVE-Lung): A randomized, double-blinded, multicenter, Phase 2 study.

The European respiratory journal·2026
Same author

Incidence of New Comorbidities After Steroid Use in Patients With Sarcoidosis: An International Cross-Sectional Survey.

Chest·2025
Same author

A paradigm shift in corticosteroid therapy for sarcoidosis: a World Association of Sarcoidosis and Other Granulomatous Disorders Position Paper, endorsed by the Americas Association of Sarcoidosis and Other Granulomatous Disorders.

The Lancet. Respiratory medicine·2025
Same author

WASOG Clinical Trial Endpoint Task Force: Executive Summary.

Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG·2025

This review examines treatments for cutaneous sarcoidosis, focusing on topical and high-concentration drugs. It provides evidence-based recommendations for managing skin sarcoidosis.

Area of Science:

  • Dermatology
  • Rheumatology
  • Internal Medicine

Background:

  • Cutaneous sarcoidosis treatments often mirror those for pulmonary sarcoidosis.
  • Some treatments are specific to skin manifestations, utilizing topical application or high drug concentrations.

Purpose of the Study:

  • To review conventional treatments for cutaneous sarcoidosis.
  • To provide evidence-based recommendations for managing skin sarcoidosis.

Main Methods:

  • Literature review of existing studies on cutaneous sarcoidosis treatments.
  • Focus on evidence quality for treatment recommendations.

Main Results:

  • Analysis of conventional treatment options for skin sarcoidosis.

Related Experiment Videos

  • Identification of treatments suitable for topical or high-concentration use.

    • Conclusions:

    • Evidence-based treatment guidelines are crucial for cutaneous sarcoidosis.
    • Tailoring treatments to skin manifestations improves management.